Adding chimeric antigen receptor–induced killer cells to the medical oncology shelf
Autor: | Brigett Brandjes, Marco L. Davila |
---|---|
Rok vydání: | 2019 |
Předmět: |
Cytotoxicity
Immunologic 0301 basic medicine T-Lymphocytes Cellular differentiation T cell Antigens CD19 Cell Separation Protein Engineering Major histocompatibility complex Immunotherapy Adoptive Cell therapy Mice 03 medical and health sciences 0302 clinical medicine CD28 Antigens Cell Line Tumor medicine Animals Humans Lymphocytes Transgenes Progenitor cell B cell Oligonucleotide Array Sequence Analysis Receptors Chimeric Antigen biology business.industry Stem Cells Tumor Suppressor Proteins Hematopoietic Stem Cell Transplantation CD28 Cell Differentiation General Medicine Flow Cytometry Chimeric antigen receptor Killer Cells Natural Repressor Proteins Phenotype 030104 developmental biology medicine.anatomical_structure 030220 oncology & carcinogenesis Commentary Cancer research biology.protein Immunotherapy business |
Zdroj: | J Clin Invest |
ISSN: | 1558-8238 0021-9738 |
Popis: | With the approval of CD19-targeted chimeric antigen receptor (CAR) T cells for the treatment of B cell malignancies, clinicians have gained valuable insights into the power and challenges of cellular therapies. In this issue of the JCI, Maluski et al. showed that a CAR containing a CD28 costimulatory domain drives progeny differentiation to resemble that of NK cells, which have the potential for an off-the-shelf cell therapy. These CAR-induced killer (CARiK) cells displayed potent antitumor function and killed across the MHC barrier in vivo. After performing in vitro and in vivo mouse studies, the authors also successfully differentiated human umbilical cord blood–derived progenitor cells into CARiK cells. These unique cells may address some of the current challenges associated with first-generation CARs, such as prolonged production that requires patients to wait weeks for infusion. We believe this innovative progenitor gene-engineered lymphoid system has the potential for clinical translation. |
Databáze: | OpenAIRE |
Externí odkaz: |